Boswell, Clay
January 2008
ICIS Chemical Business;1/28/2008, Vol. 273 Issue 4, p17
Trade Publication
The article presents the views of Jai Hiremath, vice chairman and managing director of Mumbai, India-based fine chemical company Hikal Ltd., on the future of India's pharmaceutical manufacturing sector. Hiremath hopes that India will be the heart of pharmaceutical manufacturing. He attributed the success of his company to conservative capital investment, quality improvement and strong relationships.


Related Articles

  • Hikal to Supply APIs for Pfizer in Bangalore. Ramesh, Deepti // Chemical Week;1/7/2008, Vol. 170 Issue 1, p40 

    The article reports on the long-term agreement signed by Hikal Ltd., a manufacturer of active pharmaceutical ingredients (API) and intermediates in Mumbai, India, to contract manufacture and supply API for Pfizer. Hikal will manufacture the API at its U.S. Food and Development Authority...

  • Hikal picks stake in Sinochem arm.  // Chemical Business;Dec2005, Vol. 19 Issue 12, p47 

    This article reports on a joint venture agreement signed by Hikal Ltd. by purchasing a minority stake in one of the subsidiaries of Sinochem Corp., as of December 2005. The terms of the agreement are presented. The benefits of the agreement to Hikal are highlighted. The views of Jai Hiremath,...

  • Hikal commissions Taloja plant.  // Chemical Business;Jul2008, Vol. 22 Issue 7, p72 

    The article reports on the commissioning of a multi-purpose agrochemical plant of Hikal Ltd. at Taloja in India in 2008. In a statement released by the company, vice-chairman and managing director Jai Hiremath mentioned that the plant will have a significant impact on Hikal's agrochemical...

  • Hikal Q4 net up at Rs 12.4 cr.  // Chemical Business;Jun2006, Vol. 20 Issue 6, p72 

    The article reports on the financial performance of India-based chemical manufacturer Hikal Ltd. for the fourth quarter ended March 31, 2006. Focus areas that have registered growth include the company's pharmaceutical initiatives and its agrochemicals business. Hikal posted an increase in net...

  • Hikal to invest Rs 200 crore to set up units.  // Chemical Business;Apr2008, Vol. 22 Issue 4, p87 

    The article reports on the plan of Mumbai, India-based contract research and manufacturing business Hikal to invest in establishing new manufacturing facilities in Bangalore and a research and development centre in Pune in 2008. The company has finalised an agreement with Bayer CropScience for...

  • New ICC President: Mr. Jal Hiremath.  // Chemical Business;Oct2008, Vol. 22 Issue 10, p81 

    The article announces that Jai Hiremath has been elected president of the Indian Chemical Council (ICC) for 2008-2009.

  • INDIAN SCENE.  // Chemical Business;Aug2002, Vol. 16 Issue 8, p47 

    Presents news briefs on the Indian chemical industry as of August 2002. Net profits posted by Hikal Ltd. for the quarter ended June 30, 2002; Plans of the Indian Department of Fertiliser to implement a group-based subsidy scheme for decontrolled fertilizer companies; Projections of management...

  • Hikal Acquired Pharmaceutical Fine Chemicals from Wintac. Alperowicz, Natasha // Chemical Week;3/14/2001, Vol. 163 Issue 11, p20 

    Reports on the acquisition by fine chemicals producer Hikal of the research and development and active pharmaceuticals manufacturing unit of Wintac. Aim of the acquisition; Information on an exclusive synthesis agreement of Hikal with Merck & Co.; Sales of Hikal in the fiscal year ended March...

  • Degussa discovers India. Williams, Debe // Chemical Market Reporter;4/3/2006, Vol. 269 Issue 13, p19 

    The article analyzes the long-term non-exclusive manufacturing agreement for pharmaceutical intermediates and active pharmaceutical ingredients signed by Germany's Degussa and India's Hikal in early March 2006. The move is part of Degussa's strategy of deriving a double-digit percentage of its...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics